Covered recipient · General Payments record
SUSAN SKRYPACK
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,936.66
- Reported across 133 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $693.76 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $265.71 | 7 |
| Amneal Pharmaceuticals LLC | $131.56 | 5 |
| ABBVIE INC. | $75.70 | 3 |
| Novo Nordisk AS | $67.07 | 3 |
| Amgen Inc. | $57.39 | 2 |
| Abbott Laboratories | $33.00 | 2 |
| RECORDATI_RARE_DISEASES_INC. | $21.89 | 1 |
| Medtronic, Inc. | $21.76 | 1 |
| SANOFI-AVENTIS U.S. LLC | $19.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $13.91 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124828074 | CMS |
| Abbott Laboratories | $19.09 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124828076 | CMS |
| ABBVIE INC. | $24.29 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108209398 | CMS |
| ABBVIE INC. | $27.01 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108209400 | CMS |
| ABBVIE INC. | $24.40 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108209402 | CMS |
| Amgen Inc. | $34.86 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117384975 | CMS |
| Amgen Inc. | $22.53 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117384973 | CMS |
| Amneal Pharmaceuticals LLC | $27.82 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139216890 | CMS |
| Amneal Pharmaceuticals LLC | $23.53 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139216892 | CMS |
| Amneal Pharmaceuticals LLC | $28.47 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139216894 | CMS |
| Amneal Pharmaceuticals LLC | $22.08 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139216896 | CMS |
| Amneal Pharmaceuticals LLC | $29.66 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139216898 | CMS |
| Lilly USA, LLC | $23.17 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135967138 | CMS |
| Lilly USA, LLC | $20.01 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135956263 | CMS |
| Lilly USA, LLC | $24.36 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135916715 | CMS |
| Lilly USA, LLC | $33.33 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135892878 | CMS |
| Lilly USA, LLC | $121.30 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135956265 | CMS |
| Lilly USA, LLC | $25.04 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135967140 | CMS |
| Lilly USA, LLC | $18.50 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135868972 | CMS |
| Medtronic, Inc. | $21.76 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116901848 | CMS |
| Novo Nordisk Inc | $22.02 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100411739 | CMS |
| Novo Nordisk Inc | $27.69 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100369857 | CMS |
| Novo Nordisk Inc | $17.36 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100243661 | CMS |
| RECORDATI_RARE_DISEASES_INC. | $21.89 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139170823 | CMS |
| SANOFI-AVENTIS U.S. LLC | $19.68 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139972755 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.